CME/CE

Faculty: Brian Slomovitz, MD Faculty: Casey Cosgrove, MD Faculty: Michelle Flint, WHNP-BS This series features interdisciplinary discussions on the evolving management of cervical and endometrial cancers, emphasizing biomarker-driven decision-making and personalized care. Experts examine screening, biomarker testing, clinical trial evidence, and the integration of immunotherapy into guideline-driv...

Faculty: Brian Slomovitz, MD Faculty: Casey Cosgrove, MD Faculty: Michelle Flint, WHNP-BS This series features interdisciplinary discussions on the evolving management of cervical and endometrial cancers, emphasizing biomarker-driven decision-making and personalized care. Experts examine screening, biomarker testing, clinical trial evidence, and the integration of immunotherapy into guideline-driv...

Faculty: Rajiv Agarwal, MBBS, MD, FASN, BRCU Faculty: Prof. Dr. Francesc Xavier Cos Claramunt This case-based program explores the missed opportunities in CKD detection and treatment in a patient with type 2 diabetes. Drs. Agarwal and Cos emphasize the role of primary care physicians in annual UACR screening, which can reveal kidney injury long before symptoms occur. With new evidence from the CON...

Guest: Jaime Almandoz, MD, MBA, MRCPI, FTOS, DABOM Guest: Radhika S. Breaden, MD, MPH, DABMS, DABOM Guest: H-C Carol Huang, BHB, MBChB, FRACP Guest: Babak Mokhlesi, MD, MSc Guest: Amanda J. Piper, PhD Guest: Rafael Sepulveda, MD, DABMS, DABOM Guest: Audrey Wells, MD On-demand webcast of expert faculty presentation on the connection between obstructive sleep apnea (OSA) and obesity, including strat...

Faculty: Brian Slomovitz, MD Faculty: Casey Cosgrove, MD Faculty: Michelle Flint, WHNP-BS This series features interdisciplinary discussions on the evolving management of cervical and endometrial cancers, emphasizing biomarker-driven decision-making and personalized care. Experts examine screening, biomarker testing, clinical trial evidence, and the integration of immunotherapy into guideline-driv...

Faculty: Brian Slomovitz, MD Faculty: Casey Cosgrove, MD Faculty: Michelle Flint, WHNP-BS This series features interdisciplinary discussions on the evolving management of cervical and endometrial cancers, emphasizing biomarker-driven decision-making and personalized care. Experts examine screening, biomarker testing, clinical trial evidence, and the integration of immunotherapy into guideline-driv...

Faculty: Brian Slomovitz, MD Faculty: Casey Cosgrove, MD Faculty: Michelle Flint, WHNP-BS This series features interdisciplinary discussions on the evolving management of cervical and endometrial cancers, emphasizing biomarker-driven decision-making and personalized care. Experts examine screening, biomarker testing, clinical trial evidence, and the integration of immunotherapy into guideline-driv...

Faculty: Brian Slomovitz, MD Faculty: Casey Cosgrove, MD Faculty: Michelle Flint, WHNP-BS This series features interdisciplinary discussions on the evolving management of cervical and endometrial cancers, emphasizing biomarker-driven decision-making and personalized care. Experts examine screening, biomarker testing, clinical trial evidence, and the integration of immunotherapy into guideline-driv...

Faculty: Brian Slomovitz, MD Faculty: Casey Cosgrove, MD Faculty: Michelle Flint, WHNP-BS This series features interdisciplinary discussions on the evolving management of cervical and endometrial cancers, emphasizing biomarker-driven decision-making and personalized care. Experts examine screening, biomarker testing, clinical trial evidence, and the integration of immunotherapy into guideline-driv...

Faculty: Brian Slomovitz, MD Faculty: Casey Cosgrove, MD Faculty: Michelle Flint, WHNP-BS This series features interdisciplinary discussions on the evolving management of cervical and endometrial cancers, emphasizing biomarker-driven decision-making and personalized care. Experts examine screening, biomarker testing, clinical trial evidence, and the integration of immunotherapy into guideline-driv...

Faculty: Brian Slomovitz, MD Faculty: Casey Cosgrove, MD Faculty: Michelle Flint, WHNP-BS This series features interdisciplinary discussions on the evolving management of cervical and endometrial cancers, emphasizing biomarker-driven decision-making and personalized care. Experts examine screening, biomarker testing, clinical trial evidence, and the integration of immunotherapy into guideline-driv...

Faculty: Brian Slomovitz, MD Faculty: Casey Cosgrove, MD Faculty: Michelle Flint, WHNP-BS This series features interdisciplinary discussions on the evolving management of cervical and endometrial cancers, emphasizing biomarker-driven decision-making and personalized care. Experts examine screening, biomarker testing, clinical trial evidence, and the integration of immunotherapy into guideline-driv...

Faculty: Brian Slomovitz, MD Faculty: Casey Cosgrove, MD Faculty: Michelle Flint, WHNP-BS This series features interdisciplinary discussions on the evolving management of cervical and endometrial cancers, emphasizing biomarker-driven decision-making and personalized care. Experts examine screening, biomarker testing, clinical trial evidence, and the integration of immunotherapy into guideline-driv...

Faculty: Rajiv Agarwal, MBBS, MD, FASN, BRCU Faculty: Prof. Dr. Francesc Xavier Cos Claramunt This case-based program explores the missed opportunities in CKD detection and treatment in a patient with type 2 diabetes. Drs. Agarwal and Cos emphasize the role of primary care physicians in annual UACR screening, which can reveal kidney injury long before symptoms occur. With new evidence from the CON...

Faculty: Christoph U. Correll, MD Faculty: Jonathan M. Meyer Tardive Dyskinesia (TD) is an involuntary movement disorder that can develop as a side effect of taking antipsychotic and other medications. Currently there are 2 FDA approved VMAT2 inhibitors for treating TD. Join Drs. Cristoph U. Correll and Jonathan M. Meyer for this expert discussion on the most recent data presented at the Psych Con...

Faculty: Christoph U. Correll, MD Faculty: Jonathan M. Meyer Tardive Dyskinesia (TD) is an involuntary movement disorder that can develop as a side effect of taking antipsychotic and other medications. Currently there are 2 FDA approved VMAT2 inhibitors for treating TD. Join Drs. Cristoph U. Correll and Jonathan M. Meyer for this expert discussion on the most recent data presented at the Psych Con...

Faculty: Neelam Goyal, MD Faculty: Christyn Edmundson, MD This Clinical Countdown addresses key challenges in diagnosing and managing generalized myasthenia gravis (gMG), with a focus on FcRn antagonists. Drs. Edmundson and Goyal review diagnostic challenges in gMG, along with the mechanism of FcRn blockade and how it compares to traditional therapies such as corticosteroids, IVIG, and plasma exch...

Faculty: Neelam Goyal, MD Faculty: Christyn Edmundson, MD This Clinical Countdown addresses key challenges in diagnosing and managing generalized myasthenia gravis (gMG), with a focus on FcRn antagonists. Drs. Edmundson and Goyal review diagnostic challenges in gMG, along with the mechanism of FcRn blockade and how it compares to traditional therapies such as corticosteroids, IVIG, and plasma exch...

Guest: James Burton, DM, FRCP Guest: Lucio Manenti, MD, PhD Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidimensional impact on quality of life. Learn best practices from the experts, including ho...

Guest: Leonie Kraft, MD Guest: Lucio Manenti, MD, PhD Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidimensional impact on quality of life. Learn best practices from the experts, including how to u...

Guest: Lucio Manenti, MD, PhD Guest: Emilio Sanchez, MD, PhD Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidimensional impact on quality of life. Learn best practices from the experts, including h...

Guest: James Burton, DM, FRCP Guest: Emilio Sanchez, MD, PhD Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidimensional impact on quality of life. Learn best practices from the experts, including h...

Guest: James Burton, DM, FRCP Guest: Lucio Manenti, MD, PhD Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidimensional impact on quality of life. Learn best practices from the experts, including ho...

Guest: Leonie Kraft, MD Guest: Emilio Sanchez, MD, PhD Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidimensional impact on quality of life. Learn best practices from the experts, including how to...

Guest: James Burton, DM, FRCP Guest: Emilio Sanchez, MD, PhD Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidimensional impact on quality of life. Learn best practices from the experts, including h...